Follow-up on QualiTau: How much of the 2026 backlog really depends on the Far East and China restrictions
The measurable number is already sharp: the Far East accounted for 81% of system sales in 2025 and 79.5% of backlog as of March 26, 2026. The number QualiTau still does not let investors measure is how much of that weight is specifically China, and how much sits with the same customers and the same local channels.
The Number That Can Be Measured, And The One That Cannot
The main article focused on whether QualiTau can turn backlog into cash. This follow-up isolates a narrower question: how much of the 2026 backlog really sits on the Far East, and what that means when the company itself says that from Q2/26 onward shipments to China remain subject to applicable regulatory considerations.
The first part of the answer is unusually clear. The Far East is no longer just a sales engine. It is the center of gravity of the story. In 2025 it represented $41.692 million, or 81% of system sales. On December 31, 2025 it represented $32.678 million, or 77.3% of backlog. By March 26, 2026 that weight had risen to $49.511 million, or 79.5% of a $62.276 million backlog.
The second part of the answer is less comfortable. The filings do not disclose how much of the Far East backlog is specifically China, and they do not say whether the string of Asia order announcements at the start of 2026 came from the same customer, the same customer group, or several separate accounts. So regional concentration can be measured with reasonable precision, while customer concentration and the China slice inside that region cannot. That is no longer a cosmetic disclosure gap. It is exactly where the 2026 quality test sits.
It also matters to be precise about what is not being argued. The filings do not point to weak demand. The presentation does the opposite, highlighting growth drivers such as advanced packaging, automotive, data centers, and photonics. The immediate reports from January through March 2026 prove that orders are in fact coming in. So the debate is not whether demand exists. It is whether that demand is becoming too geographically concentrated, and whether the backlog being built around it is as clean as the headline number suggests.
If the change since year-end is isolated, the picture becomes even sharper. Total backlog increased by $20.006 million by March 26, 2026. Of that, $16.833 million, or 84.1% of the increase, came from the Far East. North America added $2.72 million, and Europe plus Israel added only $0.453 million. In other words, nearly all of the new mass in backlog came from the same region that management itself marks as the main friction point.
The Immediate Reports Already Show Where The New Push Came From
Between January 7 and March 20, 2026 the company reported eight multi-system orders. Seven were defined as orders from a customer in Asia, and only one was defined as an order from a customer in the United States. In value terms, that is $15.07 million from Asia against $2.14 million from the U.S. In other words, 87.6% of the disclosed order value in that period came from Asia.
| Report date | Region | Amount | Delivery timing |
|---|---|---|---|
| January 7, 2026 | Asia | $1.32 million | Q2/26 |
| January 9, 2026 | Asia | $1.26 million | Q3/26 |
| January 13, 2026 | Asia | $1.95 million | Q3/26 |
| January 22, 2026 | Asia | $5.8 million | Q3/26 |
| March 12, 2026 | Asia | $1.7 million | Q4/26 |
| March 13, 2026 | Asia | $1.84 million | Q4/26 |
| March 13, 2026 | United States | $2.14 million | Q4/26 |
| March 20, 2026 | Asia | $1.2 million | Q4/26 |
That is not mathematical proof that every announcement translated one for one into Far East backlog. But it is a very strong directional signal. The $15.07 million of Asia announcements comes close to explaining the full $16.833 million increase in Far East backlog since year-end. So it is difficult to argue that the backlog broadened geographically. It mostly thickened further inside the same region.
There is also a subtler point here. Not every order from Asia is necessarily China, and the company does not say whether some of those announcements are repeat orders from the same customer. But that is exactly the problem: investors can see a stream of orders from Asia, yet do not get enough disclosure to know whether that stream reflects genuine diversification or deeper concentration inside the same regional bucket.
Where China Actually Enters The Story
The investor presentation does something important here. It does not just present backlog. It also makes two comments that have to be read together: Q1/26 shipments are expected to exceed the current published backlog, and from Q2/26 onward, and as always, shipments to China are subject to applicable regulatory considerations. That distinction matters.
It means the China caveat does not sit on a tiny tail. Out of the $62.276 million backlog on March 26, 2026, only $15.5 million, or 24.9%, was scheduled for Q1/26. Everything else, $46.776 million, or 75.1% of backlog, was scheduled for Q2/26 and later. Even more sharply, 96.7% of the backlog increase since year-end moved into Q2/26 and later, and 79.7% of that increase was concentrated in H2/26.
That changes how the backlog has to be read. If the regulatory caveat were attached to only a small slice of the schedule, it would be easier to treat it as noise. But when almost all of the new backlog growth lands in Q2 through Q4, and management explicitly places the China caveat there, the issue becomes part of the thesis rather than a technical footnote.
The annual report broadens that layer further. Management describes continuing U.S. policy steps meant to restrict exports of advanced technologies, tighten semiconductor supply-chain oversight, and reduce the availability of licenses and permits, alongside tariffs that may affect cost of sales. In the risk chapter, the company also states directly that restrictions could be imposed on QualiTau USA that would limit its ability to sell products developed or manufactured by it to certain customers in China. In other words, the filings themselves connect the macro export-control regime to practical sales execution.
It is also important to state what is still unknown. The filings do not break out China as a share of Far East backlog. So it would be wrong to say that 75% of backlog is exposed to China. What can be said is that the company placed the China caveat on the part of the shipment calendar that holds most of the backlog, and that is already a material statement.
Backlog Quality Depends On How It Becomes Revenue
This is the layer that turns the discussion from headline numbers into economic risk. The company says that most sales are made through ad hoc orders, that most deliveries occur within 3 to 12 months, and that normal lead times are generally 4 to 6 months from order date. It also says that payment is typically collected 30 to 60 days after shipment. In plain terms, this is not software-subscription backlog and not revenue that is already almost in the bank. This is a mass that still has to be shipped, received, and collected.
The numbers support that reading. Of the March 26, 2026 backlog, $55.363 million, or 88.9%, was product backlog, while only $6.913 million, or 11.1%, was services and testing. So if there is regulatory friction, channel complexity, or collection difficulty, it hits the core of the backlog rather than the margins.
| Quality checkpoint | What is disclosed | Why it matters |
|---|---|---|
| Backlog structure | $55.363 million products versus $6.913 million services and testing | Most of the backlog still requires physical delivery |
| Payment terms | Usually 30 to 60 days from shipment | Shipping delay can quickly become cash delay |
| Sales model | Ad hoc orders, usually 4 to 6 months to delivery | Visibility exists, but it still depends on execution |
| China and Taiwan channel | Hybrid model with local marketer helping identify customers and manage negotiations and ongoing contact | There is an extra execution layer exactly where regulatory sensitivity is higher |
There is also an interesting internal tension in the disclosure. In the marketing section the company says it has no material dependence on any one marketing channel beyond the normal burden of replacing it. But in the risk section the same report warns that rising sales to the Far East and the company’s engagement with local channels there could increase distributor leverage, especially in the Chinese market, when distribution agreements come up for renewal. That is not a full contradiction, but it is a reminder that regional concentration can quickly turn into channel concentration.
The same risk chapter adds more layers: difficulty enforcing agreements and collecting payments through local legal systems, exposure to taxes that could raise product prices, economic and political instability in the Far East with emphasis on China, the U.S.-China trade war, and tensions around Taiwan. When all of that sits next to a regional number approaching 80% of backlog, this is no longer a generic risk list. It is a direct description of the place where backlog quality will actually be tested.
Customer Concentration Is Only Partly Visible, And That Is A Yellow Flag On Its Own
The annual report gives several useful customer anchors, and they all point in the same direction. Management says that most customers are repeat sales. That is supportive, because it means demand is not one-off. But the same report also reveals concentration that is not small.
| Customer disclosed in the report | 2025 exposure | Why it matters |
|---|---|---|
| Global international manufacturer | 15% of product and service sales | One highly material customer that became visible only in 2025 |
| Nanovis Technologies Electronics | 10% | This is not just customer exposure, but also an intermediary that sells to several Far East customers |
| Leading Far East global manufacturer | 10% | Regional concentration that becomes direct exposure to a material customer |
| Leading U.S. global manufacturer | 4% | Existing exposure, but far smaller than the Far East-linked weight |
Those four disclosed anchors already add up to about 38.9% of 2025 product and service sales. That does not mean the rest of the base is concentrated to the same degree, but it does mean the company is far from a fully diffuse customer mix. More importantly, it reinforces the point that the shift from Far East revenue to Far East backlog is not just a question of regional demand. It is also a question of how much of that regional weight sits with a small number of customers and intermediaries.
What is missing is the part that matters most for 2026. The company does not say whether the Asia order announcements early in the year came through Nanovis, through separate end-customers, or through a narrow group of repeat accounts. So the conservative reading is the right one: regional concentration is certain, customer concentration is at least partly high, and the overlap between the two is probably meaningful, but the exact degree is not disclosed.
Bottom Line
The answer to the headline is two-layered. The measurable part can be measured quite well: the Far East represented 81% of system sales in 2025, 79.5% of backlog on March 26, 2026, and 87.6% of the value of multi-system orders disclosed between January and March 2026. In addition, 75.1% of the backlog sits from Q2/26 onward, exactly where the company itself attaches the China-related regulatory caveat.
The part that cannot be measured should not be smoothed away. There is no disclosure for how much of the Far East backlog is specifically China, and no adequate disclosure on whether the Asia order stream reflects broad diversification or repeated orders from the same customer base. So the heart of the story is not whether the backlog exists. It does. The real question is whether that backlog is as broad, clean, and usable as the headline number implies, or whether it rests too heavily on one region, on a small number of large accounts, and on a more complex shipment and collection environment.
For the positive reading to strengthen, three things need to happen:
- Q2 and Q3 of 2026 need to show shipments and collections that prove regulatory friction is not delaying revenue.
- The company will need to provide better disclosure on China inside the Far East bucket, or at least show wider diversification inside Asia.
- The next order stream needs to start including a broader U.S. and European base, or at minimum evidence that the Asian exposure is spread across independent customers.
Until then, QualiTau’s backlog looks strong in size, but still not clean enough in quality.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.